Demo Sign up Log In

Biocryst Pharmaceuticals Inc (BCRX)

Financing Cash Flow

$140.89M

TTM · Period ending: Jun 30, 2026 · USD

BCRX Financing Cash Flow

Latest reported$140.89Mperiod endingJun 30, 2026

Latest reported$140.89Mperiod endingJun 30, 2026

BCRX TTM Cash from Financing ($14.90M → $140.89M)

TTM financing cash flow

High-resolution chart · PNG

BCRX financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period ending	Financing Cash Flow (USD)
Jun 30, 2001	311,421
Mar 31, 2001	610,598
Dec 31, 2000	1,538,421
Sep 30, 2000	48,436,000
Jun 30, 2000	50,136,000
Mar 31, 2000	49,840,823
Dec 31, 1999	49,000,000
Sep 30, 1999	8,300,000
Jun 30, 1999	6,500,000
Mar 31, 1999	6,500,000
Dec 31, 1998	6,900,000
Sep 30, 1998	600,000
Jun 30, 1998	600,000
Mar 31, 1998	500,000
Dec 31, 1997	200,000
Sep 30, 1997	22,600,000
Jun 30, 1997	22,100,000
Mar 31, 1997	23,700,000
Dec 31, 1996	31,500,000
Sep 30, 1996	9,000,000
Jun 30, 1996	9,500,000
Mar 31, 1996	16,600,000
Dec 31, 1995	8,500,000
Sep 30, 1995	8,500,000
Jun 30, 1995	10,300,000
Mar 31, 1995	1,600,000
Dec 31, 1994	14,900,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.